Aptevo Therapeutics (APVO) Receivables (2015 - 2022)
Aptevo Therapeutics (APVO) posted Receivables of $3.1 million for Q1 2022, down 15.01% sequentially from $3.7 million in Q4 2021, and up 28.62% YoY from $2.4 million in Q1 2021.
Aptevo Therapeutics (APVO) Receivables (2015 - 2022) Analysis & Trends
Aptevo Therapeutics has reported Receivables for 8 years, with the latest figure at $3.1 million in Q1 2022.
- Quarterly Receivables rose 28.62% year-over-year to $3.1 million in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $3.1 million (up 28.62% YoY) and the FY2021 annual result came in at $3.7 million, up 54.66% from the prior year.
- Receivables fell to $3.1 million in Q1 2022 per APVO's latest filing, from $3.7 million in the prior quarter.
- Over five years, Receivables peaked at $7.9 million in Q3 2019 and troughed at $288000.0 in Q2 2020.
- A 5-year average of $4.3 million and a median of $3.4 million in 2021 frame the typical range for Receivables.
- The sharpest annual moves came in 2018 and 2020: Receivables soared 1074.62% in 2018, then plunged 96.1% in 2020.
- Over 5 years, Receivables stood at $5.2 million in 2018, then soared by 34.52% to $7.0 million in 2019, then tumbled by 66.26% to $2.4 million in 2020, then soared by 54.66% to $3.7 million in 2021, then declined by 15.01% to $3.1 million in 2022.
- According to Business Quant data, Receivables over the past three periods registered $3.1 million, $3.7 million, and $3.1 million for Q1 2022, Q4 2021, and Q3 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.47 Bn | 131.61 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.36 Bn | 78.37 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.99 Bn | 53.85 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.74 Bn | 28.43 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.01 Bn | 9.61 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | - |
| 10 | Aptevo Therapeutics | 3.18 Mn | -6.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 3.11 Mn |
| Dec 31, 2021 | 3.66 Mn |
| Sep 30, 2021 | 3.10 Mn |
| Jun 30, 2021 | 3.11 Mn |
| Mar 31, 2021 | 2.42 Mn |
| Dec 31, 2020 | 2.37 Mn |
| Sep 30, 2020 | 1.46 Mn |
| Jun 30, 2020 | 288,000.00 |
| Dec 31, 2019 | 7.02 Mn |
| Sep 30, 2019 | 7.92 Mn |
| Jun 30, 2019 | 7.38 Mn |
| Mar 31, 2019 | 5.80 Mn |
| Dec 31, 2018 | 5.22 Mn |
| Sep 30, 2018 | 6.20 Mn |
| Jun 30, 2018 | 6.15 Mn |
| Mar 31, 2018 | 3.10 Mn |
| Dec 31, 2017 | 2.14 Mn |
| Sep 30, 2017 | 528,000.00 |
| Jun 30, 2017 | 4.72 Mn |
| Mar 31, 2017 | 1.93 Mn |